CHONG KUN DANG
LIVE

Serial Number

88470347

Owner

CHONG KUN DANG HOLDINGS CORP.

Attorney

Michael T. Smith

Filing Date

Jun 12, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CHONG KUN DANG Trademark

Serial Number: 88470347 • Registration: 6166899

CHONG KUN DANG is a trademark filed by CHONG KUN DANG HOLDINGS CORP. on June 12, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

CHONG KUN DANG HOLDINGS CORP. (11 trademarks)

8 CHUNGJEONG-RO, SEODAEMUN-GU
SEOUL 120-756 , KR

Entity Type: 03

Trademark Details

Filing Date

June 12, 2019

Registration Date

October 6, 2020

Published for Opposition

July 21, 2020

Goods & Services

[ Vitamin preparations; Antibiotic preparations; Pharmaceutical agents affecting digestive organs; Pharmaceutical preparations for treating respiratory diseases; Allergy medications; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations acting on the central nervous system; Cardiovascular agents for medical purposes; Amino acids for medical purposes; Dermatological pharmaceutical preparations; Ophthalmic preparations; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for immunity adjustment; Pharmaceutical preparations, namely, antivirals; Tumor suppressing agents; Pharmaceutical preparations for treating hypertension; pharmaceutical preparations for the treatment of hyperlipidemia; Anti-inflammatories; Analgesics; Bacterial poisons; Pharmaceutical preparations for the treatment of cellular disorders; Pharmaceutical preparations for the treatment of bone diseases; Pharmaceutical preparations for use in urology; Vaccines; Nutritional supplements, namely, tonics and alternatives for medical purposes; Antibiotics; pharmaceutical preparation for the arthritis treatment; pharmaceutical preparation for the rheumarthritis treatment; Anti-cancer preparations; Pharmaceutical preparations for the prevention of cancer; Pharmaceutical preparations for the treatment of cancer; Health food supplement mainly based on lactic acid bacteria; ] Nutritional supplements, namely, probiotic compositions; [ Lactic acid bacteria in the form of capsules for medical purpose; Lactose for medical purposes; Powdered milk for babies; Calcium supplements; Powdered nutritional supplement drink mixes; ] Probiotic supplements; [ Pharmaceutical preparations for use in the treatment of diabetes, anemia, cardiovascular disease, weight loss, hormone replacement, nutritional deficiencies, infectious disease, autoimmune disease, fatigue, inflammation, pain, environmental toxicities, and heavy metal toxicities; Nutraceutical preparations for therapeutic or medical purposes in the treatment of gout; nutraceuticals for use as a dietary supplement; Anti-oxidant food supplements; Food supplements, namely, anti-oxidants; ] Food supplements [; Dietary supplements; Medicated food supplements ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jul 21, 2026 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jul 21, 2026 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 21, 2026 APRE
TEAS SECTION 8 & 15 RECEIVED
Apr 16, 2026 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 6, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Oct 6, 2020 R.PR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 2, 2020 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Sep 2, 2020 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 2, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 2, 2020 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 21, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 21, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 1, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 12, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 11, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 11, 2020 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 10, 2020 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 1, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 1, 2020 GNSL
SUSPENSION LETTER WRITTEN
Apr 1, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 11, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 11, 2020 CRFA
ASSIGNED TO LIE
Mar 9, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 3, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 5, 2019 GNRN
NON-FINAL ACTION E-MAILED
Sep 5, 2019 GNRT
NON-FINAL ACTION WRITTEN
Sep 5, 2019 CNRT
ASSIGNED TO EXAMINER
Sep 4, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 25, 2019 NWOS
NEW APPLICATION ENTERED
Jun 15, 2019 NWAP